Filing Details

Accession Number:
0000059478-19-000246
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2019-09-09 11:59:07
Reporting Period:
2019-09-03
Accepted Time:
2019-09-09 11:59:07
Original Submission Date:
2019-09-04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
59478 Lilly Eli & Co LLY Pharmaceutical Preparations (2834) 350470950
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1596336 G Alfonso Zulueta Lilly Corporate Center
Indianapolis IN 46285
Svp & President, Lilly Int'l No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-09-03 11,192 $112.88 46,614 No 4 S Direct
Common Stock Disposition 2019-09-03 3,808 $113.69 42,806 No 4 S Direct
Common Stock Disposition 2019-09-03 4,500 $112.54 38,306 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 31, 2019.
  2. This transaction is being amended to correct the price range reported on the Form 4 filed on 09/04/19. This transaction was executed in multiple trades at prices ranging from $112.50 to $113.49. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. This transaction is being amended to correct the price range reported on the Form 4 filed on 09/04/19. This transaction was executed in multiple trades at prices ranging from $113.50 to $113.85. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  4. This transaction is being amended to correct the total number of shares and price previously reported as part of multiple trades on the Form 4 filed on 09/04/19. This transaction was executed in one trade at a price of $112.54. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.